High-dose IL-2 for metastatic renal cell carcinoma: can the first antitumor immunotherapy be reinvented?

Immunotherapy

PubMedID: 25341116

Muhitch JB, Schwaab T. High-dose IL-2 for metastatic renal cell carcinoma: can the first antitumor immunotherapy be reinvented?. Immunotherapy. 2014;6(9):955-958.
An abstract is not available. Please access the article through the links below.